Premium Information is available for this item - Upgrade for $1 a day
6550-01-503-3071
Human Serum Control Set
6550015033071 015033071 123521
January 2023
3
Marketplace 6550-01-503-3071
Request a Quotation from participating marketplace vendors
Related Documents 6550-01-503-3071 5+ Documents (More...)
6550-01-609-7033 Set 6550014800616 486-5431 6550-41-001-0632 6550-01-579-2847 6550-01-486-5426 6550-01-503-3071
/fsg-65/fsc-6550/us 6550-01-609-7033 Human Serum Control Set 6550016097033 6550-01-486-5426 6550-01-503-3071
609-7033 9999-99-126-5637 https/ 486-5431 6550-41-001-0632 6550-01-579-2847 6550-01-486-5426 6550-01-503-3071
126-56379999991265637991265637 CONTROL SET,HUMAN https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-503-3071
Human Serum Control Set 6550015033071,123521 6550-01-579-2847 6550-01-486-5426 6550-01-503-3071
Serum Control Set 6550014800616 486-5431 6550-41-001-0632 6550-01-579-2847 6550-01-486-5426 6550-01-503-3071
6550/us 6550-01-503-3072 https//www.nsnlookup.com /cage Bayer Corp (CAGE Code 3CJL2) Dec 2002 6550-01-503-3071
486-5427 6550-01-486-5428 6550-01-486-5431 6550-41-001-0632 6550-01-579-2847 6550-01-486-5426 6550-01-503-3071
486-5427 6550-01-486-5428 6550-01-486-5431 6550-41-001-0632 6550-01-579-2847 6550-01-486-5426 6550-01-503-3071
Restrictions 6550-01-503-3071
6550-01-503-3071 is a Human Serum Control Set that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6550-01-503-3071
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6550-01-503-3071
- Turkey (ZW01)
- Effective Date:
- 1 Dec 2002
Approved Sources 6550-01-503-3071
- Part Number
- Manufacturer
- Status
- 123521
- Manufacturer
- 3CJL2 - Bayer Corp (Active)
- Primary Buy
- Primary Buy
Datasheet 6550-01-503-3071
- Characteristic
- Specifications
- FIIG
- Specifications
- A23800
- Special Features [FEAT]
- 5 Ready Pack Primary Reagent Packs Containing Advia Centuar Ca19-9 Lite Reagent And Solid Phase Advia Centuar Ca19-9 Master Curve Card; Sample Vol 75 Ul; For In Vitro Diagnostic Use In Determination Of Ca19-9 In Human Serum And To Aid In Management Of Gi Carcinoma Using The Advia Centuar Chemoluminescence Analyzer In A Hospital/Lab Setting; Us Law Restricts This Device To Sale And Distribution By Or On The Order Of A Dr Or To A Clinical Lab; Ca19-9 Is A Tumor Associated Antigen Which Reacts W/An Antibody Produced In Response To Immunization W/A Human Colon Cancer Cell Line; Also Useful In Detecting Pancreatic Cancer
NATO Stock Numbers Related to 6550-01-503-3071
Freight Information 6550-01-503-3071
6550-01-503-3071 has freight characteristics managed by Turkey.. 6550-01-503-3071 has a variance between NMFC and UFC when transported by rail and the description should be consulted.